Chemed (NYSE:CHE) CEO Sells $806,360.00 in Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the sale, the chief executive officer directly owned 93,719 shares in the company, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Chemed Stock Up 0.6%

NYSE CHE traded up $2.31 on Friday, reaching $401.86. 124,709 shares of the stock traded hands, compared to its average volume of 203,754. Chemed Corporation has a 12 month low of $385.00 and a 12 month high of $623.60. The company has a market cap of $5.53 billion, a price-to-earnings ratio of 21.89, a P/E/G ratio of 1.60 and a beta of 0.46. The firm’s fifty day simple moving average is $441.92 and its 200 day simple moving average is $441.34.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The firm had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. During the same period in the prior year, the firm posted $6.83 EPS. The firm’s quarterly revenue was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Monday, February 23rd will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s dividend payout ratio is currently 13.06%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $498.00.

Institutional Trading of Chemed

Hedge funds have recently modified their holdings of the business. Monetary Solutions Ltd purchased a new position in shares of Chemed during the fourth quarter valued at $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed in the 4th quarter worth about $26,000. Smartleaf Asset Management LLC boosted its position in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares during the period. BOK Financial Private Wealth Inc. purchased a new position in Chemed during the 4th quarter valued at about $27,000. Finally, First Horizon Corp acquired a new position in shares of Chemed in the 3rd quarter valued at about $31,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.